Related Experiment Videos
Dehydroepiandrosterone replacement therapy
1Division of Medical Sciences, Institute of Biomedical Research, University of Birmingham, Birmingham, United Kingdom. w.arlt@bham.ac.uk
Seminars in Reproductive Medicine
|January 7, 2005
Summary
Dehydroepiandrosterone (DHEA) replacement therapy benefits patients with adrenal insufficiency (AI), improving well-being and libido. However, DHEA is not recommended for healthy aging individuals or postmenopausal women without established androgen deficiency.
Area of Science:
- Endocrinology
- Neuroendocrinology
- Reproductive Medicine
Background:
- Dehydroepiandrosterone (DHEA) replacement therapy is increasingly studied.
- DHEA deficiency, particularly in adrenal insufficiency (AI), impacts well-being, energy, mood, and libido.
- DHEA influences sex steroid metabolism and possesses neurosteroidal properties.
Purpose of the Study:
- To evaluate the efficacy of DHEA replacement therapy in various patient populations.
- To differentiate therapeutic benefits in conditions of DHEA deficiency versus physiological decline.
Main Methods:
- Review of existing literature and clinical trial data on DHEA replacement therapy.
- Analysis of DHEA's metabolic pathways and neurobiological actions.
Main Results:
- Significant benefits observed in patients with complete DHEA deficiency (AI), including improved mood and libido.
- DHEA may offer a glucocorticoid-sparing effect in systemic lupus erythematosus.
- Evidence does not support DHEA use in healthy elderly or postmenopausal women without specific androgen deficiency.
Conclusions:
- DHEA replacement is beneficial for patients with adrenal insufficiency and potentially for those on chronic glucocorticoids or with systemic lupus erythematosus.
- Caution is advised for DHEA use in cases of relative DHEA decline, such as aging.
- DHEA may be suitable for androgen replacement in women with surgically induced or premature menopause-related androgen deficiency.